To the full analysis
Buyback calculator for HUTCHMED (China)
HUTCHMED (China) stock: dividend
HCMHUTCHMED (China) does not currently pay a dividend. From fiscal 2023 to 2025, HUTCHMED (China) bought back its own shares for $45.14M.
Whether HUTCHMED (China) Limited pays a dividend and what the company does with its cash instead: free cash flow, buybacks of its own shares and the share count over recent years.
Daily figure as of 13 Nov 2026
Free cash flow and buybacks
| Fiscal year | Free cash flow | Share buybacks | Shares outstanding |
|---|---|---|---|
| 2025 | −$88.81M | $0 | 171.66M |
| 2024 | −$17.44M | $36.06M | 171.07M |
| 2023 | $186.65M | $9.07M | 169.93M |
| 2022 | −$305.26M | $48.08M | 169.43M |
| 2021 | −$220.98M | $27.31M | 158.54M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 24 Apr 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.